LXRX

Lexicon Pharmaceuticals, Inc.

Investor Moves

NameValueActionChangePriceLast Price
Steven CohenPoint72
$12M7.8M shares
AddQ1 2026
$12M
$1.45
$2.28
Ken GriffinCitadel Advisors
$3M1.7M shares
AddQ1 2026
$23k
$1.45
$2.28
Jim SimonsRenaissance Technologies
$2M1.6M shares
AddQ1 2026
$2M
$1.45
$2.28
Jefferies GroupInvestor
$107k68.7k shares
AddQ1 2026
$815
$1.45
$2.28

Insider Trades

NameValueActionPriceLast Price
Debbane RaymondDirector
$3k2k shares
BuyFeb 25, 2026
$1.49
$2.28
Debbane RaymondDirector
$147k100k shares
BuyFeb 23, 2026
$1.47
$2.28
Debbane RaymondDirector
$148k100k shares
BuyFeb 20, 2026
$1.48
$2.28
Debbane RaymondDirector
$72k50k shares
BuyFeb 19, 2026
$1.44
$2.28
Debbane RaymondDirector
$176k133.7k shares
BuyFeb 18, 2026
$1.32
$2.28
Debbane RaymondDirector
$101k76.9k shares
BuyFeb 17, 2026
$1.31
$2.28

News

fool.comLexicon Pharmaceuticals vs. Pfizer: Which Drugmaker Stock Is a Better Buy in 2026?fool.comJun 11globenewswire.comLexicon to Present Data at the American Diabetes Association (ADA) 2026 Scientific Sessionsglobenewswire.comJun 3globenewswire.comLexicon Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conferenceglobenewswire.comMay 28globenewswire.comLexicon Pharmaceuticals to Present at the 4th Annual H.C. Wainwright BioConnect Investor Conferenceglobenewswire.comMay 12marketbeat.comLexicon Pharmaceuticals Q1 Earnings Call Highlightsmarketbeat.comMay 8